This inventor holds 1 USPTO granted patent. Top assignee: Chinese Academy of Sciences. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Lanmin Li in Pharmaceutical Chemistry
Introduction
Lanmin Li is a notable inventor based in Parla, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on coumarin derivatives. His research focuses on developing new drug compositions aimed at treating various health conditions.
Latest Patents
Lanmin Li holds a patent for "Coumarin-amide derivatives and its preparation, said drug composition and its use." This invention relates to novel coumarin derivatives and their carboxamides. The pharmaceutical compositions containing these compounds are designed for kidney protection and the treatment of hypertension, cardio-cerebrovascular diseases, non-insulin dependent diabetes, tumors, pre-cancerous lesions, and edemas. His work in this area highlights the potential of these compounds in addressing critical health issues.
Career Highlights
Lanmin Li is affiliated with the Chinese Academy of Sciences, where he conducts his research. His position at this prestigious institution allows him to collaborate with other leading scientists and contribute to advancements in pharmaceutical sciences. His dedication to research and innovation has positioned him as a key figure in his field.
Collaborations
Some of Lanmin Li's notable coworkers include Shiping Xu and Song Xu. Their collaborative efforts in research have further enhanced the impact of their work in pharmaceutical chemistry.
Conclusion
Lanmin Li's innovative contributions to the development of coumarin derivatives demonstrate his commitment to advancing medical science. His work has the potential to significantly improve treatment options for various diseases, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
